APA (7th ed.) Citation

M, M., M, G., A, M., E, P., P, V., L, S., . . . M, F. (2026). Substrates of 8.5-year clinical outcomes in aquaporin-4 IgG-positive neuromyelitis optica spectrum disorders. Journal of neurology, 273(2), 112. https://doi.org/10.1007/s00415-026-13647-x

Chicago Style (17th ed.) Citation

M, Margoni, et al. "Substrates of 8.5-year Clinical Outcomes in Aquaporin-4 IgG-positive Neuromyelitis Optica Spectrum Disorders." Journal of Neurology 273, no. 2 (2026): 112. https://doi.org/10.1007/s00415-026-13647-x.

MLA (9th ed.) Citation

M, Margoni, et al. "Substrates of 8.5-year Clinical Outcomes in Aquaporin-4 IgG-positive Neuromyelitis Optica Spectrum Disorders." Journal of Neurology, vol. 273, no. 2, 2026, p. 112, https://doi.org/10.1007/s00415-026-13647-x.